Important information regarding the contacts and business relationships that you make through the B2B MARKET PLACE, keep in mind that:

  1. PROCOLOMBIA accompanies companies with the purpose of facilitating business opportunities between exporters and buyers, without intervening in purchase and/or sale decisions, therefore, the contractual and legal responsibility of commercial negotiations falls directly on the companies that carried out the commercial transaction (exporter and buyer).
  2. Although PROCOLOMBIA carries out a preliminary investigation of the companies as part of its work methodology and commercial management, this process does not constitute any guarantee of compliance in the negotiations between the parties, for this reason it is recommended that both the exporter and the buyer carry out their own validations and protect their commercial operations with the mechanisms available in international trade regulations.
  3. The relationship between PROCOLOMBIA and the companies in Colombia and abroad, is generated through trust and the experience acquired from previous actions; however, such companies may present situations that could lead to possible breaches, without these being the responsibility of PROCOLOMBIA, which is why both exporters and buyers must ensure that they use secure negotiation tools, seek advice from experts to assess commercial risks and formalize the contractual documents that may be necessary to shield their conversations.
  4. ProColombia will in no case be responsible for the information of the companies and/or products available on this platform since it is filled out completely by each one of the companies.

Pharmaceutical companies in colombia

With a growing pharmaceutical company and manufacturing industry, a well established healthcare system, and sustainable investment on health research, Colombia continues to be an attractive place for investors and international companies to put their bet on the country.

What positions Colombia as one of the best pharma manufacturers in Latin America is its biodiversity, flexible trade agreements allowing the country to be a great exportation hub and access to innovative technology.

The country’s rich biodiversity offers great opportunity to develop natural products attracting more global companies.

The local production of generic drugs, over-the-counter pharmaceutical products and patent medicines has created a great potential to attract new global markets and multinational companies.

In 2015, pharmaceutical and chemical supplier companies in Colombia exported goods that were worth $525.4 million U.S dollars.
Pharmacy laboratories and pharmaceutical companies in Colombia are well equipped in terms of technology to meet the quality and production standards needed to deliver the best high end pharmacy supplies.

Bogota, the capital of Colombia, holds most of the country’s market with 66% of pharma manufacturers producing pharmaceutical products and where 65% are wholesalers distributors. The city is responsible for 47% of all exportation becoming an important hub to develop chemical synthesis medicines.

The main export destinations are Ecuador, Venezuela, Peru, Panama and the United States.

It is expected for the Colombian pharmaceutical market to grow at a rate of around 7.3 percent and reach a USD 7.1 billion valuation by 2020.
There is no doubt that Colombia offers a great deal for regional production and distribution hubs for pharmaceutical products.


260 result(s) found